Study results indicate that moderate aerobic exercise may improve physical functioning in men who are receiving radiation therapy for localized prostate cancer and this improved physical functioning may... Continue Reading

Xgeva™ (denosumab) has been approved by the US Food and Drug Administration (FDA) for the prevention of bone complications such as fracture in patients with bone metastases from solid (not blood-related)... Continue Reading

Among women with bone metastases from breast cancer, denosumab may be more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. The results of this Phase... Continue Reading

Compared with standard therapies, Nplate® (romiplostim) appears to reduce the risk of treatment failure and need for splenectomy among adult patients with chronic immune thrombocytopenia (ITP). These... Continue Reading

People with a history of cancer appear to be 40% more likely to experience memory problems than people with no history of cancer. These findings were recently presented at the Third American Association... Continue Reading

Most cancer patients who experience pain or depression also report many accompanying physical symptoms such as fatigue, difficulty sleeping, difficulty remembering things, and extremity, joint, or back... Continue Reading

A European study of anemia and cancer reports that anemia is common in lung cancer patients and often untreated. Results from the European Cancer Anemia Survey (ECAS) suggest that anemia is common in... Continue Reading

Early-stage breast cancer patients undergoing radiation therapy following breast-conserving surgery experienced significantly less skin irritation when they used a melatonin-containing cream compared with... Continue Reading

Among patients with multiple myeloma or bone metastases from breast cancer, prostate cancer, or other solid tumors, denosumab was more effective than Zometa® (zoledronic acid) at delaying or preventing... Continue Reading

According to an article published in the Annals of Oncology, survivors of Hodgkin’s lymphoma have a significantly increased rate of cardiac and thyroid complications than their siblings. In addition,... Continue Reading